Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
240.00    -5.00 (-2.04%)
Bid:
244.00
Ask:
250.50
Spread: 6.50 (2.664%)
Market Cap: £140.01m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

AGM Statement

5 Dec 2019 07:00

RNS Number : 7186V
MJ Gleeson PLC
05 December 2019
 

MJ Gleeson plc

(GLE.L)

 

AGM Statement

 

MJ Gleeson plc (GLE.L), the low-cost housebuilder and strategic land specialist, will today hold its Annual General Meeting in Sheffield. Dermot Gleeson, Chairman, will make the following comments:

"Demand at Gleeson Homes is strong with net reservations since the start of the current financial year to 30 June 2020 ("FY2020") up more than 10% compared with the same period last year.

"Land continues to be available at sensible prices and the pipeline remains strong. Gleeson Homes has a pipeline of 13,042 plots with a gross development value of £1.7 billion, of which 6,910 plots are owned and 6,132 are conditionally purchased.

"The division currently has 64 active sites, compared with 62 at this time last year, but expects to open significantly more sites in the second half of FY2020.

"Strong demand, good mortgage availability and our ability to offer attractive levels of affordability to our customers, means the outlook for the division remains very positive.

 

"The Board expects Gleeson Homes to record an increase in completions for the half year to 31 December 2019 of approximately 10% compared with the prior half year total of 691 units; and an increase in completions for FY2020 of at least 10% compared with the prior year total of 1,529 units.

"Gleeson Strategic Land continues to experience strong demand for consented land. The majority of the division's land sales are expected in the second half of FY2020. Accordingly, and in line with our expectations, results for the first half are expected to be lower than the unusually high results for the first half last year.

"The division's land pipeline currently consists of 64 sites which have the potential to deliver approximately 22,175 plots. The portfolio includes 10 sites which now have planning permission.

"Against this background the Board remains confident that the Group's results for FY2020 will be in line with expectations.

"We announced in September the appointment of Andrew Coppel and Fiona Goldsmith to the Board as non-executive Directors with effect from 1st October 2019. Colin Dearlove, Senior Independent Director and Ross Ancell, Non-Executive Director will be stepping down from the Board in June 2020. The Board would like to thank both Colin and Ross for the invaluable guidance and support they have provided over the years."

 

5 December 2019

 

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of the company is Stefan Allanson, Chief Financial Officer.

 

LEI: 21380064K7N2W7FD6434

 

Enquiries:

MJ Gleeson plc

Tel: +44 1142 612900

James Thomson

Chief Executive Officer

Stefan Allanson

Chief Financial Officer

Instinctif Partners

Tel: +44 20 7457 2020

Mark Garraway

James Gray

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

Rachel Hayes

Liberum

Neil Patel

Tel: +44 20 3100 2222

Richard Bootle

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMKMMGZVDGGLZM
Date   Source Headline
12th Dec 20227:00 amRNSAppointment of Managing Director of Gleeson Land
8th Dec 20221:26 pmRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSTotal Voting Rights
28th Nov 20223:46 pmRNSDirector/PDMR Shareholding
18th Nov 20221:05 pmRNSResult of AGM
18th Nov 20227:00 amRNSAGM Trading Update
8th Nov 202212:34 pmRNSDirector/PDMR Shareholding
4th Nov 20221:31 pmRNSDirector/PDMR Shareholding
1st Nov 20227:00 amRNSRe: Financial Calendar
31st Oct 20227:00 amRNSTotal Voting Rights
21st Oct 20224:21 pmRNSPerformance Share Plan award to Directors & PDMRs
20th Oct 20227:00 amRNSNotice of AGM
12th Oct 20227:00 amRNSRe Directorate
7th Oct 20224:41 pmRNSSecond Price Monitoring Extn
7th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Oct 20221:25 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSRe Directorate External Appointments
5th Oct 20224:15 pmRNSExercise of Options & PDMR Dealing
3rd Oct 202211:55 amRNSDirector/PDMR Shareholding
30th Sep 20227:00 amRNSTotal Voting Rights
15th Sep 20227:00 amRNSFinal Results
7th Sep 20229:50 amRNSDirector/PDMR Shareholding
31st Aug 20227:00 amRNSTotal Voting Rights
9th Aug 20229:41 amRNSDirector/PDMR Shareholding
1st Aug 202211:28 amRNSNotification of Transaction by Directors/PCA
29th Jul 20227:00 amRNSTotal Voting Rights
14th Jul 20222:26 pmRNSDirector/PDMR Shareholding
11th Jul 20227:00 amRNSTrading Update & Notice of Results
7th Jul 20229:35 amRNSDirector/PDMR Shareholding
1st Jul 20227:05 amRNSMJ Gleeson achieves medium-term strategic target
30th Jun 20227:00 amRNSTotal Voting Rights
8th Jun 20222:53 pmRNSDirector/PDMR Shareholding
31st May 20227:00 amRNSTotal Voting Rights
12th May 20227:00 amRNSNotice of Trading Update & Results
10th May 20229:54 amRNSDirector/PDMR Shareholding
9th May 20227:00 amRNSAppointment of Group Sustainability Manager
4th May 20221:09 pmRNSDirector/PDMR Shareholding
29th Apr 20223:30 pmRNSTotal Voting Rights
29th Apr 20227:00 amRNSDirector/PDMR Shareholding
27th Apr 20227:00 amRNSRe Directorate Change
12th Apr 20224:51 pmRNSDirector/PDMR Shareholding
6th Apr 20227:00 amRNSRe DLUHC pledge
31st Mar 20227:00 amRNSTotal Voting Rights
25th Mar 20227:00 amRNSDirectorate changes and committee appointments
17th Mar 20227:00 amRNSDirectorate Change
11th Mar 20224:41 pmRNSSecond Price Monitoring Extn
11th Mar 20224:36 pmRNSPrice Monitoring Extension
10th Mar 20229:54 amRNSDirector/PDMR Shareholding
10th Feb 20227:00 amRNSHalf-year Report
8th Feb 20224:20 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.